Department of Internal Medicine, Zuyderland Medical Centre, Sittard/Heerlen, The Netherlands.
Department of Internal Medicine and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
Hypertens Res. 2018 Sep;41(9):639-648. doi: 10.1038/s41440-018-0063-z. Epub 2018 Jul 3.
Fibromuscular dysplasia is a heterogeneous group of systemic, noninflammatory, and nonatherosclerotic diseases of the vascular wall. It is the second-most common abnormality of the renal artery. Although hypertension is the most common presenting symptom, other symptoms, such as pulsatile tinnitus, stroke, chest pain, or abdominal discomfort, may result from other affected vascular beds. Revascularization of the renal artery appears to be effective at lowering blood pressure in many patients with renal artery fibromuscular dysplasia. For a long time, the intrarenal pathophysiological changes and mechanisms leading to hypertension had hardly been studied in patients with renal artery fibromuscular dysplasia. Recent data, however, has provided more insight into the effects of renal artery fibromuscular dysplasia on the intrarenal microvasculature and the intra-renal renin-angiotensin system in these patients. Moreover, these data have changed our view of the pathophysiological mechanisms leading to hypertension in patients with renal artery fibromuscular dysplasia. In this review, we will discuss recent clinical and scientific developments regarding renal artery fibromuscular dysplasia with an emphasis on its effects on the kidney.
纤维肌性发育不良是一种系统性、非炎症性、非动脉粥样硬化性的血管壁疾病,具有异质性。它是肾动脉最常见的第二种异常。尽管高血压是最常见的表现症状,但其他症状,如搏动性耳鸣、中风、胸痛或腹部不适,可能源于其他受影响的血管床。肾动脉再血管化似乎能有效降低许多肾动脉纤维肌性发育不良患者的血压。长期以来,肾动脉纤维肌性发育不良患者的肾内病理生理变化和导致高血压的机制几乎没有得到研究。然而,最近的数据提供了更多关于肾动脉纤维肌性发育不良对这些患者肾内微血管和肾内肾素-血管紧张素系统的影响的见解。此外,这些数据改变了我们对导致肾动脉纤维肌性发育不良患者高血压的病理生理机制的看法。在这篇综述中,我们将讨论肾动脉纤维肌性发育不良的最新临床和科学进展,重点是其对肾脏的影响。